Carlyle Secured Lending (CGBD) reported third-quarter net investment income of $0.36 per share, missing the $0.37 consensus by 2.7% and falling 5.3% from a year ago. Revenue of $63.2 million beat the $42.43 million consensus by 49.0% but fell 5.0% year over year. The oversized revenue beat says more about the bar than the business. Total investment income was essentially unchanged from the second quarter's $62 million. The central tension is that the income line appears to have stabilized while the inputs that drive future income are weakening.

On earnings quality, the quarter was cleaner than the slight miss suggests. GAAP NII and adjusted NII were identical at $0.36, so acquisition-accounting adjustments did not flatter the result. NII improved from $0.35 in the second quarter and covered the $0.35 quarterly dividend the Board declared again for January. That dividend level reflects the earlier reset from $0.40, so coverage was restored by lowering the bar. Still, it is now being cleared.

Net asset value per share rose 0.3% to $15.65 from $15.61. That reverses a slide from $16.26 at the end of 2025 and $15.89 in the first quarter. The bigger improvement was below the NII line. Realized and unrealized losses shrank to roughly $1 million, or $0.02 per share, from $24 million in the second quarter and $29 million in the first.

The call explained why management sounded steady rather than celebratory. Deployment fell sharply. CGBD funded just $81 million in the quarter, down from $248 million in the second quarter and more than $400 million in the record fourth quarter of 2025. Repayments of $129 million left the portfolio flat at $2.3 billion. Management was selective given an uncertain backdrop and conceded that fourth-quarter originations will likely stay muted. Its constructive outlook is now framed as a medium-term view that depends on geopolitical certainty. The pipeline was described as 'steady' rather than 'active.' That is a clear step back from the expectation of an active 2026 voiced at the start of the year.

Credit is the other soft spot. Non-accruals roughly doubled to 1.1% of fair value and 2.2% of cost, from 0.6% and 1.2%, after two names were added. Median portfolio EBITDA also slipped to $97 million from $101 million.

The offsets are real but uneven in durability. New origination spreads of about 505 basis points are roughly 35 basis points wider than late-2025 levels. Entry leverage fell to 4.9x, and PIK income declined. Management also described Carlyle's proprietary sourcing as producing about half of platform originations at wider spreads.

The joint ventures remain the earnings engine:

• MMCF's dividend yield climbed to 18.4% from 17.6% in the second quarter and about 15% in the first.
• SCP grew to $2.1 billion from $1.7 billion, yielding 20.3%. However, management flagged that yield as temporarily elevated by settlement timing and guided to a normalized mid-teens level.
• SCP's dividend exceeded its GAAP NII, which tempers how much of the JV uplift investors should extrapolate.

Rates have flipped from headwind to tailwind. After a 25-basis-point Fed hike in September and expectations for two or three more through 2027, management framed the nearly fully floating-rate portfolio as an earnings tailwind. That reverses the rate-cut concerns of earlier calls. The risk is that higher rates also strain borrowers, and non-accruals are already rising. Management also cited volatility around AI compute debt issuance, along with looser structures and tighter pricing in that sector.

Investor sentiment shifted meaningfully, moving from negative (-0.28) at the prior report to modestly positive (+0.16). The stock has been less enthusiastic. Shares at $10.89 are up 2.2% since the open after the August report and sit 2.1% below the 200-day moving average of $11.12. The price remains roughly 30% below NAV. Against that discount, the $300 million buyback reauthorization through November 2027 stands out. So does the fact that repurchases slowed to $6.1 million from $12.5 million in the second quarter and $19 million in the first. Bears can reasonably ask why management is buying less stock at a deep discount while statutory leverage rose to 1.26x from 1.2x.

The bottom line is that the third quarter supports the view that the second quarter marked CGBD's earnings trough. NII now covers the reset dividend, NAV has stopped falling, and rising rates plus JV growth give the income line support. But a portfolio that is not growing, a doubling in non-accruals, and a pushed-out origination recovery mean the next leg depends on credit holding up and deal activity returning in 2027. Investors have warmed to that story. The stock's position below its 200-day average and its steep NAV discount show the market still wants evidence that this stability can turn into growth.